[Federal Register Volume 60, Number 110 (Thursday, June 8, 1995)] [Notices] [Page 30320] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 95-13990] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 16, 1995, Johnson & Johnson Pharmaceutical Partners, HC02 State Road 933, KMO.1 Mamey Ward, HC-02 Box 19250, Gurabo, Puerto Rico 00778-9629, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Alfentanil (9737).................... II Sufentanil (9740).................... II ------------------------------------------------------------------------ The firm plans to manufacture the listed controlled substances for bulk distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. Any such comments, objections, or requests for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than July 10, 1995. Dated: May 30, 1995. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 95-13990 Filed 6-7-95; 8:45 am] BILLING CODE 4410-09-M